| WKN: | A2JA9Q |
| ISIN: | US77313F1066 |
| Land: | USA |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Biotechnologie |
Weshalb die Inotek Pharmaceuticals-Aktie
ein D-Rating hat,
erfahren Sie im Performance-Check
vom 10. März 2026 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2020 | 21,20 | 44,80 | 111,32% |
| 2 | 2019 | 11,81 | 21,20 | 79,51% |
| 3 | 2023 | 17,99 | 27,93 | 55,25% |
| 4 | 2026 | 2,75 | 3,80 | 38,18% |
| 5 | 2018 | 8,73 | 11,81 | 35,28% |
| 6 | 2022 | 19,70 | 17,99 | -8,68% |
| 7 | 2016 | 39,52 | 24,32 | -38,46% |
| 8 | 2021 | 44,80 | 19,70 | -56,03% |
| 9 | 2024 | 27,93 | 10,83 | -61,22% |
| 10 | 2017 | 24,32 | 8,73 | -64,10% |
| 11 | 2025 | 10,83 | 2,75 | -74,61% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2025 | 10,83 | 2,75 | -74,61% |
| 2 | 2017 | 24,32 | 8,73 | -64,10% |
| 3 | 2024 | 27,93 | 10,83 | -61,22% |
| 4 | 2021 | 44,80 | 19,70 | -56,03% |
| 5 | 2016 | 39,52 | 24,32 | -38,46% |
| 6 | 2022 | 19,70 | 17,99 | -8,68% |
| 7 | 2018 | 8,73 | 11,81 | 35,28% |
| 8 | 2026 | 2,75 | 3,80 | 38,18% |
| 9 | 2023 | 17,99 | 27,93 | 55,25% |
| 10 | 2019 | 11,81 | 21,20 | 79,51% |
| 11 | 2020 | 21,20 | 44,80 | 111,32% |